European Concerted Action on Cystic Fibrosis
Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis
Abstract
These recommendations for quality improvement of cystic fibrosis genetic diagnostic testing provide general guidelines for the molecular genetic testing of cystic fibrosis in patients/individuals. General strategies for testing as well as guidelines for laboratory procedures, internal and external quality assurance, and for reporting the results, including the requirements of minimal services in mutation testing, the nomenclature for describing mutations, procedures to control false-positive amplification reactions and to validate tests, and guidelines to implement a quality system in a molecular diagnostic laboratory are reviewed.
Source and rights
Published by European journal of human genetics : EJHG, 2000. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- European Concerted Action on Cystic Fibrosis
- Published
- 2000
- Applies to
- 🇪🇺 Europe
- Country of origin
- 🇧🇪 Belgium
- Scope
- Regional
- Journal
- European journal of human genetics : EJHG
- PubMed
- 11108532











